Ranbaxy Lab shoots up on registering 4-folds increase in Q1CY12 consolidated net profit

09 May 2012 Evaluate

Drug maker Ranbaxy Laboratories has reported higher than expected profit for the quarter ended March 31, 2012

The Company has posted a net profit of Rs 827.23 crore for Q1 CY12 as compared to net loss of Rs 52.90 crore for theQ1CY11. Company’s total income has increased by 72.26% to Rs 2050.11 crore for the quarter as compared to Rs 1190.14 crore for the similar quarter of previous fiscal.

On consolidated basis, group’s net profit after tax, minority interest and share of profit of associates zoomed by 309.59% at Rs 1246.76 crore for the January-March quarter as compared to Rs 304.39 crore for the similar quarter a period ago. Group’s total income has risen by 71.84% to Rs 3923.47 crore for the quarter under review from Rs 2283.19 crore for the quarter ended March 31, 2011.

Ranbaxy Laboratories is currently trading at Rs 514.10, up by 20.40 points or 4.13% from its previous closing of Rs 493.70 on the BSE.

The scrip opened at Rs 498.15 and has touched a high and low of Rs 517.75 and Rs 492.65 respectively. So far 505010 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 5 has touched a 52 week high of Rs 570.00 on 02-Aug-2011 and a 52 week low of Rs 366.50 on 19-Dec-2011.

Last one week high and low of the scrip stood at Rs 517.75 and Rs 491.10 respectively. The current market cap of the company is Rs 21766.24 crore.

The promoters holding in the company stood at 63.67% while Institutions and Non-Institutions held 20.47% and 13.82% respectively.

The estimates were that the group would report a growth of 34% year-on-year in its profit after tax at Rs 408 crore for the first quarter of CY12.

As of March 2012, Ranbaxy had 45% market share in the Lipitor generic market. In Q4, Lipitor generic contributed $300 million to revenues and market share was 42% with price erosion of 65%.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×